Colon cancer consultation for staging, chemotherapy planning, targeted therapy, follow-up care, and personalized treatment decisions.
Colon cancer develops in the large intestine and may cause bowel changes, bleeding, anemia, abdominal pain, or weight loss.
Treatment depends on stage, surgery findings, pathology, molecular markers, and patient condition.
Early diagnosis and proper staging help decide whether surgery, chemotherapy, targeted therapy, or immunotherapy is needed.
The most common type — starts in the milk ducts and invades surrounding tissue. Accounts for about 80% of all breast cancer cases.
Begins in the lobules (milk-producing glands). Often harder to detect on imaging; requires careful clinical evaluation.
Overexpresses the HER2 protein, making it more aggressive — but highly responsive to targeted therapies like trastuzumab (Herceptin).
Lacks ER, PR, and HER2 receptors. More aggressive and treated primarily with chemotherapy and newer immunotherapy agents.
Fuelled by estrogen or progesterone. Responds well to hormone-blocking therapies such as tamoxifen or aromatase inhibitors.
A rare, rapidly progressing form that causes redness and swelling. Requires immediate, aggressive multimodal treatment.
Recognising early symptoms leads to earlier diagnosis and better outcomes.
Helps identify and biopsy the tumor.
Confirms diagnosis.
Used for staging.
Useful for monitoring.
Helps assess immunotherapy suitability in selected cases.
Treatment depends on type, stage, and patient health. Dr. Kumar designs individualised plans:
Outcomes depend on stage, subtype, and treatment response. Modern treatments have significantly improved survival:
Better outcomes with timely treatment.
Chemotherapy may reduce recurrence risk.
Systemic therapy helps disease control.
Book an appointment with Dr. Shikhar Kumar for colon cancer treatment planning, chemotherapy guidance, and report review.
Share your details and our team will help you schedule a consultation for cancer care, treatment guidance, or report review.